Neurofilaments as biomarkers in multiple sclerosis

Antigen microarrays identify CNS-produced autoantibodies in RRMS

(2012) F. J. Quintana et al.   NEUROLOGY

The neurofilament light chain is not stable in vitro

(2011) Marleen J.A. Koel-Simmelink et al.   ANNALS OF NEUROLOGY

Neurofilament stoichiometry simulations during neurodegeneration suggest a remarkable self-sufficient and stable in vivo protein structure

(2011) Seonghoon Kim et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis

(2011) J. Kuhle et al.   NEUROLOGY

Evidence for acute neurotoxicity after chemotherapy

(2010) Axel Petzold et al.   ANNALS OF NEUROLOGY

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

(2010) Martin Gunnarsson et al.   ANNALS OF NEUROLOGY

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis

(2010) Manuel Comabella et al.   BRAIN

A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein

(2010) Jens Kuhle et al.   JOURNAL OF NEUROIMMUNOLOGY

Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis

(2010) M. Axelsson et al.   JOURNAL OF NEUROLOGY

A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament “hook” effect

(2010) Ching-Hua Lu et al.   JOURNAL OF NEUROSCIENCE METHODS

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers

(2010) Jan Ottervald et al.   Journal of Proteomics

Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event

(2010) Olivier Gout et al.   Multiple Sclerosis Journal

Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM

(2010) Patrizia Sola et al.   Multiple Sclerosis Journal

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course

(2010) Mohsen Khademi et al.   Multiple Sclerosis Journal

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)

(2010) Johannes Brettschneider et al.   PLoS One

EFNS guidelines on disease-specific CSF investigations

(2009) F. Deisenhammer et al.   EUROPEAN JOURNAL OF NEUROLOGY

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

(2009) F. Sellebjerg et al.   NEUROLOGY

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

(2009) C. E. Teunissen et al.   NEUROLOGY

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis

(2008) M Thangarajh et al.   Multiple Sclerosis Journal

Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry

(2008) Marcel P. Stoop et al.   PROTEOMICS